ANALYSIS OF STRUCTURAL FEATURES OF THE KETO-KETAL ISOMERS OF WARFARIN BY SPECTRAL METHODS
Abstract
As a result of the studies was shown that the relative ratios of isomers by integration in DMSO-d6: (S, R)-warfarin – (S, S)-warfarin – open chain warfarin are 70%: 28%: 2%; in СDCl3 are 45%: 40%: 15%. In the IR spectra of warfarin specific absorption bands are observed in the regions 3271–3277 cm-1, 1681–1682 cm-1, 1103–1076 cm-1, corresponding to:νOH, νCH=CH: νas C–O–C. The molecular peak of warfarin after silylation has m/z 380 corresponding to the mass of trimethylsilyl-warfarin. Thus, the possibility of using IR, NMR spectroscopy and chromatography-mass spectrometry to confirm the authenticity of warfarin derivatives has been demonstrated.
About the Authors
A. Z. Abyshev
St. Petersburg Chemical and Pharmaceutical Academy, Ministry of Healthcare
Russian Federation
Russian Federation
K. B. Nguyen
St. Petersburg Chemical and Pharmaceutical Academy, Ministry of Healthcare
Russian Federation
Russian Federation
L. N. Zinchuk
St. Petersburg Chemical and Pharmaceutical Academy, Ministry of Healthcare
Russian Federation
Russian Federation
References
1. А.З. Абышев, Э.М. Агаев, Р.А. Абышев. Природные и снтетические кумарины и флавоноиды. - Баку: Наука и образование, 2014. 482 с.
2. M. Wadelius et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose // The pharmacogenomics journal. 2005. V. 5. № 4. P. 262-270.
3. L. Guasch, M.L. Peach, M.C. Nicklaus. Tautomerism of warfarin: combined chemoinformatics, quantum chemical, and NMR investigation // The Journal of organic chemistry. 2015. V. 80. № 20. P. 9900-9909.
4. E.J. Valente et al. Structure of warfarin in solution // Journal of medicinal chemistry. 1977. V. 20. № 11. P. 1489-1493.
5. D.A. Barnette et al. Stereospecific Metabolism of R-and S-Warfarin by Human Hepatic Cytosolic Reductases // Drug Metabolism and Disposition. 2017. V. 45. № 9. P. 1000-1007.
6. Martindale: The Complete Drug Reference. 36th Edition / Ed. by S.С. Sweetman. - London: Pharmaceutical Press, 2009. 3694 p.
7. M. He et al. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9 // Archives of biochemistry and biophysics. 1999. V. 372. № 1. P. 16-28.
8. M.J. Fasco, L.M. Principe. R-and S-Warfarin inhibition of vitamin K and vitamin K 2, 3-epoxide reductase activities in the rat // Journal of Biological Chemistry. 1982. V. 257. № 9. P. 4894-4901.
Review
For citations:
Abyshev A.Z., Nguyen K.B., Zinchuk L.N. ANALYSIS OF STRUCTURAL FEATURES OF THE KETO-KETAL ISOMERS OF WARFARIN BY SPECTRAL METHODS. Drug development & registration. 2018;(1):138-145. (In Russ.)
Views:
681
Email this article 